{"id":59609,"date":"2026-03-16T16:10:46","date_gmt":"2026-03-16T08:10:46","guid":{"rendered":"https:\/\/flcube.com\/?p=59609"},"modified":"2026-03-16T16:10:46","modified_gmt":"2026-03-16T08:10:46","slug":"chinas-basic-medical-insurance-covers-1-33-billion-in-2025-nhsa-reports-rmb-3-6-trillion-fund-inflows-114-new-drugs-added-to-nrdl","status":"publish","type":"post","link":"https:\/\/flcube.com\/?p=59609","title":{"rendered":"China’s Basic Medical Insurance Covers 1.33\u202fBillion in 2025 \u2013 NHSA Reports RMB 3.6\u202fTrillion Fund Inflows, 114 New Drugs Added to NRDL"},"content":{"rendered":"\n

China’s National Healthcare Security Administration (NHSA)<\/strong> released its 2025 Healthcare Security Development Statistical Bulletin<\/strong>, revealing that Basic Medical Insurance (BMI)<\/strong> participation reached 1.33\u202fbillion people<\/strong> (coverage rate >95%<\/strong>), with fund inflows totaling RMB\u202f3,587.3\u202fbillion (USD\u202f520\u202fbillion)<\/strong> against expenditures of RMB\u202f3,000.9\u202fbillion (USD\u202f440\u202fbillion)<\/strong>. The 2025 NRDL update added 114 new drugs<\/strong>, bringing total covered medicines to 3,253<\/strong>, while DRG\/DIP payment reform<\/strong> now covers >95% of inpatient cases<\/strong> and inter-provincial direct settlement<\/strong> surged 30.17% for outpatient visits<\/strong>, demonstrating sustained universal health coverage expansion<\/strong> and cost control efficiency<\/strong>.<\/p>\n\n\n\n

BMI Coverage and Fund Performance<\/h2>\n\n\n\n
Metric<\/th>2025 Result<\/th>Change (YOY)<\/th>Strategic Note<\/th><\/tr><\/thead>
BMI Participants<\/strong><\/td>1.33\u202fbillion<\/td>+4.06\u202fmillion<\/td>>95% coverage rate maintained<\/td><\/tr>
Maternity Insurance<\/strong><\/td>259.7\u202fmillion<\/td>+6.7\u202fmillion<\/td>Expanded social safety net<\/td><\/tr>
Fund Inflows<\/strong><\/td>RMB\u202f3,587.3\u202fbn (USD\u202f520\u202fbn)<\/td>\u2014<\/td>Sustainable revenue base<\/td><\/tr>
Fund Expenditures<\/strong><\/td>RMB\u202f3,000.9\u202fbn (USD\u202f440\u202fbn)<\/td>\u2014<\/td>83.6% inflow-to-outflow ratio<\/td><\/tr>
Maternity Benefits<\/strong><\/td>RMB\u202f136\u202fbn (USD\u202f19.7\u202fbn)<\/td>\u2014<\/td>Direct patient support<\/td><\/tr>
Fund Balance<\/strong><\/td>RMB\u202f586.4\u202fbn (USD\u202f85\u202fbn)<\/td>\u2014<\/td>Reserve for future obligations<\/td><\/tr><\/tbody><\/table><\/figure>\n\n\n\n

Healthcare Utilization Trends<\/h2>\n\n\n\n
Service Type<\/th>2025 Volume<\/th>Change (YOY)<\/th>Implication<\/th><\/tr><\/thead>
Outpatient Visits<\/strong><\/td>7.215\u202fbillion<\/td>+25.51%<\/strong><\/td>Shift to ambulatory care; COVID recovery; chronic disease management<\/td><\/tr>
Inpatient Visits<\/strong><\/td>278\u202fmillion<\/td>\u20133.40%<\/strong><\/td>DRG\/DIP cost control reducing unnecessary admissions<\/td><\/tr>
Average Inpatient Cost<\/strong><\/td>RMB\u202f8,509.28 (USD\u202f1,233)<\/td>\u2014<\/td>Cost containment stable<\/td><\/tr>
Low-Income Rural Access<\/strong><\/td>246.3\u202fmillion beneficiaries<\/td>\u2014<\/td>Triple protection system (BMI + major illness insurance + medical assistance)<\/td><\/tr>
Expense Reduction<\/strong><\/td>RMB\u202f193.39\u202fbn (USD\u202f28\u202fbn)<\/td>\u2014<\/td>Catastrophic health expenditure protection<\/td><\/tr><\/tbody><\/table><\/figure>\n\n\n\n

NRDL and Drug Access<\/h2>\n\n\n\n
Element<\/th>2025 Data<\/th>Strategic Impact<\/th><\/tr><\/thead>
Total Covered Medicines<\/strong><\/td>3,253<\/td>Comprehensive formulary<\/td><\/tr>
Western Medicines<\/strong><\/td>1,857<\/td>Innovation access<\/td><\/tr>
Chinese Patent Medicines<\/strong><\/td>1,396<\/td>Traditional medicine integration<\/td><\/tr>
Prepared Slices<\/strong><\/td>892<\/td>Herbal medicine standardization<\/td><\/tr>
New Drugs Added<\/strong><\/td>114<\/strong><\/td>Annual innovation refresh; market access for pharma<\/strong><\/td><\/tr>
Negotiation Drug Visits<\/strong><\/td>>240\u202fmillion<\/td>High utilization of price-negotiated innovative drugs<\/td><\/tr><\/tbody><\/table><\/figure>\n\n\n\n

Payment Reform and Cost Control<\/h2>\n\n\n\n
Reform Initiative<\/th>2025 Coverage<\/th>Efficiency Metric<\/th><\/tr><\/thead>
DRG\/DIP Implementation<\/strong><\/td>>95% of planning areas<\/td>Case-based payment standardization<\/td><\/tr>
Short-Term Inpatient DRG\/DIP<\/strong><\/td>>95% of cases<\/td>Prospective payment controlling costs<\/td><\/tr>
Inpatient Pooling Fund DRG\/DIP<\/strong><\/td>>80% of expenditures<\/td>Fund sustainability protection<\/td><\/tr>
Five Supporting Mechanisms<\/strong><\/td>100% of pooling regions<\/td>Exceptional review, advance payment, feedback, negotiation, data working groups<\/td><\/tr>
Data Transparency<\/strong><\/td>>95% publish biannually<\/td>Accountability and provider benchmarking<\/td><\/tr>
Cross-Province DRG\/DIP<\/strong><\/td>All provinces initiated<\/td>National payment harmonization<\/td><\/tr><\/tbody><\/table><\/figure>\n\n\n\n

Centralized Procurement and Price Reform<\/h2>\n\n\n\n
Initiative<\/th>2025 Achievement<\/th>Market Impact<\/th><\/tr><\/thead>
Medical Service Price Guidelines<\/strong><\/td>39 batches issued<\/td>National price item unification<\/td><\/tr>
Provincial Implementation<\/strong><\/td>Most completed 30 batches<\/td>Standardized pricing across regions<\/td><\/tr>
Dynamic Adjustment Triggers<\/strong><\/td>23 provinces\/cities eligible<\/td>Routine price updates for provider viability<\/td><\/tr>
11th National Drug Procurement<\/strong><\/td>55 drugs covered<\/td>Continued generic price reduction<\/td><\/tr>
6th High-Value Consumables Procurement<\/strong><\/td>12 types (drug-coated balloons, urological devices)<\/td>Medical device cost containment<\/td><\/tr><\/tbody><\/table><\/figure>\n\n\n\n

Fund Supervision and Anti-Fraud<\/h2>\n\n\n\n
Metric<\/th>2025 Result<\/th>Enforcement Mechanism<\/th><\/tr><\/thead>
Total Fund Recovery<\/strong><\/td>RMB\u202f34.2\u202fbn (USD\u202f4.96\u202fbn)<\/td>Comprehensive audit and monitoring<\/td><\/tr>
AI Monitoring Recovery<\/strong><\/td>RMB\u202f3\u202fbn (USD\u202f434\u202fmn)<\/td>Intelligent monitoring subsystem deployment<\/td><\/tr>
Whistleblower Rewards<\/strong><\/td>RMB\u202f1.558\u202fmn (USD\u202f226\u202fk)<\/td>Public reporting incentives<\/td><\/tr>
Whistleblower Recovery<\/strong><\/td>RMB\u202f2.74\u202fbn (USD\u202f397\u202fmn)<\/td>Citizen engagement in fraud detection<\/td><\/tr><\/tbody><\/table><\/figure>\n\n\n\n

Inter-Provincial Settlement Network<\/h2>\n\n\n\n
Network Component<\/th>2025 Scale<\/th>Growth (YOY)<\/th><\/tr><\/thead>
Designated Medical Institutions<\/strong><\/td>655,800<\/td>Expanded national network<\/td><\/tr>
Designated Hospitals<\/strong><\/td>241,800<\/td>Inpatient access<\/td><\/tr>
Designated Pharmacies<\/strong><\/td>414,000<\/td>Retail access<\/td><\/tr>
Inpatient Cross-Province Settlement<\/strong><\/td>15.823\u202fmillion visits<\/td>+10.38%<\/strong><\/td><\/tr>
Outpatient Cross-Province Settlement<\/strong><\/td>292\u202fmillion visits<\/td>+30.17%<\/strong><\/td><\/tr><\/tbody><\/table><\/figure>\n\n\n\n

Forward\u2011Looking Statements<\/strong>
This brief contains forward\u2011looking statements regarding BMI sustainability, NRDL expansion, and payment reform implementation based on NHSA 2025 statistical data. Actual results may differ due to demographic shifts, economic growth variations, and healthcare demand inflation.-Fineline Info & Tech<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"

China’s National Healthcare Security Administration (NHSA) released its 2025 Healthcare Security Development Statistical Bulletin, revealing…<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"googlesitekit_rrm_CAownpewDA:productID":"","_jetpack_memberships_contains_paid_content":false,"footnotes":"","jetpack_publicize_message":"","jetpack_publicize_feature_enabled":true,"jetpack_social_post_already_shared":true,"jetpack_social_options":{"image_generator_settings":{"template":"highway","default_image_id":0,"font":"","enabled":false},"version":2}},"categories":[4],"tags":[92,67],"class_list":["post-59609","post","type-post","status-publish","format-standard","hentry","category-policy-regulatory","tag-bmi","tag-nhsa-prev-smia"],"yoast_head":"\nChina's Basic Medical Insurance Covers 1.33\u202fBillion in 2025 \u2013 NHSA Reports RMB 3.6\u202fTrillion Fund Inflows, 114 New Drugs Added to NRDL - Insight, China's Pharmaceutical Industry<\/title>\n<meta name=\"description\" content=\"China's National Healthcare Security Administration (NHSA) released its 2025 Healthcare Security Development Statistical Bulletin, revealing that Basic Medical Insurance (BMI) participation reached 1.33\u202fbillion people (coverage rate >95%), with fund inflows totaling RMB\u202f3,587.3\u202fbillion (USD\u202f520\u202fbillion) against expenditures of RMB\u202f3,000.9\u202fbillion (USD\u202f440\u202fbillion). The 2025 NRDL update added 114 new drugs, bringing total covered medicines to 3,253, while DRG\/DIP payment reform now covers >95% of inpatient cases and inter-provincial direct settlement surged 30.17% for outpatient visits, demonstrating sustained universal health coverage expansion and cost control efficiency.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/flcube.com\/?p=59609\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"China's Basic Medical Insurance Covers 1.33\u202fBillion in 2025 \u2013 NHSA Reports RMB 3.6\u202fTrillion Fund Inflows, 114 New Drugs Added to NRDL\" \/>\n<meta property=\"og:description\" content=\"China's National Healthcare Security Administration (NHSA) released its 2025 Healthcare Security Development Statistical Bulletin, revealing that Basic Medical Insurance (BMI) participation reached 1.33\u202fbillion people (coverage rate >95%), with fund inflows totaling RMB\u202f3,587.3\u202fbillion (USD\u202f520\u202fbillion) against expenditures of RMB\u202f3,000.9\u202fbillion (USD\u202f440\u202fbillion). The 2025 NRDL update added 114 new drugs, bringing total covered medicines to 3,253, while DRG\/DIP payment reform now covers >95% of inpatient cases and inter-provincial direct settlement surged 30.17% for outpatient visits, demonstrating sustained universal health coverage expansion and cost control efficiency.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/flcube.com\/?p=59609\" \/>\n<meta property=\"og:site_name\" content=\"Insight, China's Pharmaceutical Industry\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/profile.php?id=61566606313834\" \/>\n<meta property=\"article:published_time\" content=\"2026-03-16T08:10:46+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/flcube.com\/wp-content\/uploads\/2024\/11\/Fineline-info-tech-scaled.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"2560\" \/>\n\t<meta property=\"og:image:height\" content=\"1894\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Fineline Cube\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:description\" content=\"Navigate the complexities of China\u2019s pharmaceutical industry with precision and clarity. FLCUBE delivers reliable data, news, and intelligence to broaden your horizons and sharpen your decision-making. Stay informed, stay ahead with FLCUBE.COM\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Fineline Cube\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=59609#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=59609\"},\"author\":{\"name\":\"Fineline Cube\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/person\\\/19ad11870d326204db8524d3c3c5e66a\"},\"headline\":\"China’s Basic Medical Insurance Covers 1.33\u202fBillion in 2025 \u2013 NHSA Reports RMB 3.6\u202fTrillion Fund Inflows, 114 New Drugs Added to NRDL\",\"datePublished\":\"2026-03-16T08:10:46+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=59609\"},\"wordCount\":538,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\"},\"keywords\":[\"BMI\",\"NHSA (prev. SMIA)\"],\"articleSection\":[\"Policy \\\/ Regulatory\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\\\/\\\/flcube.com\\\/?p=59609#respond\"]}],\"copyrightYear\":\"2026\",\"copyrightHolder\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\"}},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=59609\",\"url\":\"https:\\\/\\\/flcube.com\\\/?p=59609\",\"name\":\"China's Basic Medical Insurance Covers 1.33\u202fBillion in 2025 \u2013 NHSA Reports RMB 3.6\u202fTrillion Fund Inflows, 114 New Drugs Added to NRDL - Insight, China's Pharmaceutical Industry\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#website\"},\"datePublished\":\"2026-03-16T08:10:46+00:00\",\"description\":\"China's National Healthcare Security Administration (NHSA) released its 2025 Healthcare Security Development Statistical Bulletin, revealing that Basic Medical Insurance (BMI) participation reached 1.33\u202fbillion people (coverage rate >95%), with fund inflows totaling RMB\u202f3,587.3\u202fbillion (USD\u202f520\u202fbillion) against expenditures of RMB\u202f3,000.9\u202fbillion (USD\u202f440\u202fbillion). The 2025 NRDL update added 114 new drugs, bringing total covered medicines to 3,253, while DRG\\\/DIP payment reform now covers >95% of inpatient cases and inter-provincial direct settlement surged 30.17% for outpatient visits, demonstrating sustained universal health coverage expansion and cost control efficiency.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=59609#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/flcube.com\\\/?p=59609\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=59609#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/flcube.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"China’s Basic Medical Insurance Covers 1.33\u202fBillion in 2025 \u2013 NHSA Reports RMB 3.6\u202fTrillion Fund Inflows, 114 New Drugs Added to NRDL\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#website\",\"url\":\"https:\\\/\\\/flcube.com\\\/\",\"name\":\"Insight, China's Pharmaceutical Industry\",\"description\":\"Fineline Insights, Pharma Clarity\",\"publisher\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/flcube.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\",\"name\":\"Fineline Infomation and Technology\",\"alternateName\":\"Fineline Info & Tech\",\"url\":\"https:\\\/\\\/flcube.com\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2024\\\/11\\\/Fineline-info-tech-scaled.jpg\",\"contentUrl\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2024\\\/11\\\/Fineline-info-tech-scaled.jpg\",\"width\":2560,\"height\":1894,\"caption\":\"Fineline Infomation and Technology\"},\"image\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/profile.php?id=61566606313834\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/person\\\/19ad11870d326204db8524d3c3c5e66a\",\"name\":\"Fineline Cube\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g\",\"caption\":\"Fineline Cube\"},\"sameAs\":[\"https:\\\/\\\/flcube.com\"],\"url\":\"https:\\\/\\\/flcube.com\\\/?author=1\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"China's Basic Medical Insurance Covers 1.33\u202fBillion in 2025 \u2013 NHSA Reports RMB 3.6\u202fTrillion Fund Inflows, 114 New Drugs Added to NRDL - Insight, China's Pharmaceutical Industry","description":"China's National Healthcare Security Administration (NHSA) released its 2025 Healthcare Security Development Statistical Bulletin, revealing that Basic Medical Insurance (BMI) participation reached 1.33\u202fbillion people (coverage rate >95%), with fund inflows totaling RMB\u202f3,587.3\u202fbillion (USD\u202f520\u202fbillion) against expenditures of RMB\u202f3,000.9\u202fbillion (USD\u202f440\u202fbillion). The 2025 NRDL update added 114 new drugs, bringing total covered medicines to 3,253, while DRG\/DIP payment reform now covers >95% of inpatient cases and inter-provincial direct settlement surged 30.17% for outpatient visits, demonstrating sustained universal health coverage expansion and cost control efficiency.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/flcube.com\/?p=59609","og_locale":"en_US","og_type":"article","og_title":"China's Basic Medical Insurance Covers 1.33\u202fBillion in 2025 \u2013 NHSA Reports RMB 3.6\u202fTrillion Fund Inflows, 114 New Drugs Added to NRDL","og_description":"China's National Healthcare Security Administration (NHSA) released its 2025 Healthcare Security Development Statistical Bulletin, revealing that Basic Medical Insurance (BMI) participation reached 1.33\u202fbillion people (coverage rate >95%), with fund inflows totaling RMB\u202f3,587.3\u202fbillion (USD\u202f520\u202fbillion) against expenditures of RMB\u202f3,000.9\u202fbillion (USD\u202f440\u202fbillion). The 2025 NRDL update added 114 new drugs, bringing total covered medicines to 3,253, while DRG\/DIP payment reform now covers >95% of inpatient cases and inter-provincial direct settlement surged 30.17% for outpatient visits, demonstrating sustained universal health coverage expansion and cost control efficiency.","og_url":"https:\/\/flcube.com\/?p=59609","og_site_name":"Insight, China's Pharmaceutical Industry","article_publisher":"https:\/\/www.facebook.com\/profile.php?id=61566606313834","article_published_time":"2026-03-16T08:10:46+00:00","og_image":[{"width":2560,"height":1894,"url":"https:\/\/flcube.com\/wp-content\/uploads\/2024\/11\/Fineline-info-tech-scaled.jpg","type":"image\/jpeg"}],"author":"Fineline Cube","twitter_card":"summary_large_image","twitter_description":"Navigate the complexities of China\u2019s pharmaceutical industry with precision and clarity. FLCUBE delivers reliable data, news, and intelligence to broaden your horizons and sharpen your decision-making. Stay informed, stay ahead with FLCUBE.COM","twitter_misc":{"Written by":"Fineline Cube","Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/flcube.com\/?p=59609#article","isPartOf":{"@id":"https:\/\/flcube.com\/?p=59609"},"author":{"name":"Fineline Cube","@id":"https:\/\/flcube.com\/#\/schema\/person\/19ad11870d326204db8524d3c3c5e66a"},"headline":"China’s Basic Medical Insurance Covers 1.33\u202fBillion in 2025 \u2013 NHSA Reports RMB 3.6\u202fTrillion Fund Inflows, 114 New Drugs Added to NRDL","datePublished":"2026-03-16T08:10:46+00:00","mainEntityOfPage":{"@id":"https:\/\/flcube.com\/?p=59609"},"wordCount":538,"commentCount":0,"publisher":{"@id":"https:\/\/flcube.com\/#organization"},"keywords":["BMI","NHSA (prev. SMIA)"],"articleSection":["Policy \/ Regulatory"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/flcube.com\/?p=59609#respond"]}],"copyrightYear":"2026","copyrightHolder":{"@id":"https:\/\/flcube.com\/#organization"}},{"@type":"WebPage","@id":"https:\/\/flcube.com\/?p=59609","url":"https:\/\/flcube.com\/?p=59609","name":"China's Basic Medical Insurance Covers 1.33\u202fBillion in 2025 \u2013 NHSA Reports RMB 3.6\u202fTrillion Fund Inflows, 114 New Drugs Added to NRDL - Insight, China's Pharmaceutical Industry","isPartOf":{"@id":"https:\/\/flcube.com\/#website"},"datePublished":"2026-03-16T08:10:46+00:00","description":"China's National Healthcare Security Administration (NHSA) released its 2025 Healthcare Security Development Statistical Bulletin, revealing that Basic Medical Insurance (BMI) participation reached 1.33\u202fbillion people (coverage rate >95%), with fund inflows totaling RMB\u202f3,587.3\u202fbillion (USD\u202f520\u202fbillion) against expenditures of RMB\u202f3,000.9\u202fbillion (USD\u202f440\u202fbillion). The 2025 NRDL update added 114 new drugs, bringing total covered medicines to 3,253, while DRG\/DIP payment reform now covers >95% of inpatient cases and inter-provincial direct settlement surged 30.17% for outpatient visits, demonstrating sustained universal health coverage expansion and cost control efficiency.","breadcrumb":{"@id":"https:\/\/flcube.com\/?p=59609#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/flcube.com\/?p=59609"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/flcube.com\/?p=59609#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/flcube.com\/"},{"@type":"ListItem","position":2,"name":"China’s Basic Medical Insurance Covers 1.33\u202fBillion in 2025 \u2013 NHSA Reports RMB 3.6\u202fTrillion Fund Inflows, 114 New Drugs Added to NRDL"}]},{"@type":"WebSite","@id":"https:\/\/flcube.com\/#website","url":"https:\/\/flcube.com\/","name":"Insight, China's Pharmaceutical Industry","description":"Fineline Insights, Pharma Clarity","publisher":{"@id":"https:\/\/flcube.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/flcube.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/flcube.com\/#organization","name":"Fineline Infomation and Technology","alternateName":"Fineline Info & Tech","url":"https:\/\/flcube.com\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/flcube.com\/#\/schema\/logo\/image\/","url":"https:\/\/flcube.com\/wp-content\/uploads\/2024\/11\/Fineline-info-tech-scaled.jpg","contentUrl":"https:\/\/flcube.com\/wp-content\/uploads\/2024\/11\/Fineline-info-tech-scaled.jpg","width":2560,"height":1894,"caption":"Fineline Infomation and Technology"},"image":{"@id":"https:\/\/flcube.com\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/profile.php?id=61566606313834"]},{"@type":"Person","@id":"https:\/\/flcube.com\/#\/schema\/person\/19ad11870d326204db8524d3c3c5e66a","name":"Fineline Cube","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g","caption":"Fineline Cube"},"sameAs":["https:\/\/flcube.com"],"url":"https:\/\/flcube.com\/?author=1"}]}},"jetpack_publicize_connections":[],"jetpack_featured_media_url":"","jetpack_sharing_enabled":true,"_links":{"self":[{"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts\/59609","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=59609"}],"version-history":[{"count":1,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts\/59609\/revisions"}],"predecessor-version":[{"id":59611,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts\/59609\/revisions\/59611"}],"wp:attachment":[{"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=59609"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=59609"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=59609"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}